FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...